OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020

    NEXT STORY
    Allogene Therapeutics and MD Anderson Announce Strategic Collaboration to Accelerate Advancement of Allogeneic CAR T Therapy (AlloCAR T™)
    PREV STORY
    OncXerna Therapeutics to Participate at the Jefferies Virtual London Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Black Diamond Therapeutics Announces the Appointment of Biopharmaceutical Veteran Robert A. Ingram as Chairman of the Board

    author_avatar
    NASDAQ Market News

    Positive clinical phase III results of vortioxetine in Japanese adults with Major Depressive Disorder

    New clinical phase III data from a study conducted in Japan demonstrate the efficacy ...

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

    author_avatar
    NASDAQ Market News